2 ms·
With FDA-approved "breakthrough" status, the treatment could be approved as early as 2021. Also, for the more business-oriented crowd here, the business model
by Glench 9y ago
With FDA-approved "breakthrough" status, the treatment could be approved as early as 2021.
Also, for the more business-oriented crowd here, the business model for MAPS is really interesting. There's a MAPS benefit corporation that plans to manufacture and sell regulated MDMA when MDMA-assisted therapy becomes legal. Their plan is to use all the profits from that b-corp to fund more research done by the main MAPS non-profit.
I saw a talk by the director, Rick Doblin, where he said that fundraising was taking most of their time which made doing the actual research difficult. Their plan to make a sustainable benefit that directly funds the research is a super interesting idea and I hope it works out. The world needs more examples of sustainable organizations doing work that really benefits human happiness.